Novo Nordisk's once-weekly insulin hits goals in phase 3 trials
Coronary Artery Disease Pipeline Offers Promising New Treatment Options as 23+ Leading Players are Working in the Space | DelveInsight - Netscape Entertainment
2022 Pipeline Report: Capitalizing on Opportunity
R&D pipeline
Novo Nordisk: This Winner Has Risks, Be Aware (NYSE:NVO) | Seeking Alpha
Eli Lilly and Co and Novo Nordisk AS Among Leading Companies in the Type 2 Diabetes Pipeline Market
Now online: 2021 Access to Medicine Index | Access to Medicine Foundation
Why Is Novo Nordisk Losing Its Steam And Is It Sustainable Or Not? (NYSE:NVO) | Seeking Alpha
Novo Nordisk AS Medical Pipeline Products - GlobalData
Novo Nordisk: Continuing The Growth, But Stock May Have Gotten Ahead Of Itself (NYSE:NVO) | Seeking Alpha
Can Novo Nordisk's pipeline transform obesity treatment? -
Has the pipe run dry for Novo Nordisk? :: Scrip
Novo Nordisk invests $100m in diabetes pipeline purification plant
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
R&D pipeline
Pharm Exec's 2020 Pipeline Report
Novo Nordisk's Innovative Research and Development Pipeline
A Royal Reception for Obesity Research - ConscienHealth
